Pay in 4 interest-free payments of $22.88 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Sofosbuvir 13CD3 (PSI-7977 13CD3) is the deuterium labeled Sofosbuvir
InChiKey: ZPHYPKKFSHAVOE-YZIXBPQXSA-N
1'-biphenyl]-4-yl)methyl)benzenesulfonamide
951 are approximately 2000-fold selective for the glycine binding site relative to the glutamate recognition sites
Sitagliptin phosphate ine(Oxedrine) Sofosbuvir 13CD3 (PSI-7977 13CD3) isSitagliptin (INN; previously identified as MK 0431 and sold under the trade name Januvia) is an oral antihyperglycemic (anti diabetic drug) of the dipeptidyl peptidase 4 (DPP 4) inhibitor class. It was developed and is marketed by Merck & Co. This enzyme inhibiting drug is used either alone or in combination with other oral antihyperglycemic agents (such as metformin or a thiazolidinedione) for treatment of diabetes mellitus type 2. The benefit of
US$ 68.00
US$ 46.00
US$ 25.00
US$ 22.00
US$ 23.00
US$ 27.00
US$ 15.00
US$ 144.00